about
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusCD8 T cell persistence in treated HIV infectionImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Short communication: high cellular iron levels are associated with increased HIV infection and replication.Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ARTElevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease OnsetFrailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.Residual inflammation and viral reservoirs: alliance against an HIV cure.Thymosin alpha 1 and HIV-1: recent advances and future perspectives.Immunosenescence and hurdles in the clinical management of older HIV-patients.Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection.Elevated Level of CD4+ T Cell Immune Activation in Acutely HIV-1-Infected Stage Associates With Increased IL-2 Production and Cycling Expression, and Subsequent CD4+ T Cell Preservation.Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells.
P2860
Q26851535-0D466D92-37CB-40EC-9881-066D98304443Q27014768-F4FB64C4-FB41-46F9-A60D-D803CCBD9E9DQ30362489-FDB8A492-1E72-4764-88FC-931AAFA58143Q30367583-219B4B1A-69C2-4118-94E2-BEE8CE6C5F77Q31152445-BDA4C78A-645B-4638-96D4-30B58E2BE8ABQ35991216-30E9E811-B863-4761-8DFB-8B17E1A187A4Q36100333-B5E7CDAD-C021-450C-8437-D40157AC1A40Q36276469-FEF957F7-5519-491B-8AFF-DDB15481560AQ38269458-48E155F7-7E16-45E7-A6A5-E94C9853B212Q38768132-39CB6DA2-43AD-4C33-A170-AB81633572AAQ39170367-3118F7E2-E409-4176-946A-8E50481BA1B8Q40507828-41829A95-A0B4-4277-8D95-F4161C47314DQ40786980-6852FAF4-F620-4DB5-AB21-34A81D1BA931Q47139254-DA52AEF8-F969-4D24-A3FE-FAAC5E41C45AQ52595184-33C05059-DAAD-4764-A0BF-B024FF04C045Q52653716-89E378B1-4533-4B44-98D4-E44BDE07B533
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Can early therapy reduce inflammation?
@ast
Can early therapy reduce inflammation?
@en
Can early therapy reduce inflammation?
@nl
type
label
Can early therapy reduce inflammation?
@ast
Can early therapy reduce inflammation?
@en
Can early therapy reduce inflammation?
@nl
prefLabel
Can early therapy reduce inflammation?
@ast
Can early therapy reduce inflammation?
@en
Can early therapy reduce inflammation?
@nl
P2860
P1476
Can early therapy reduce inflammation?
@en
P2860
P356
10.1097/COH.0000000000000020
P577
2014-01-01T00:00:00Z